Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.91x is 39% above its 5-year average of -3.12x, near the high end of its 5-year range (-68.49x–-0.26x).
19.13% above its 12-month average of -2.36x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2027 (2026-06-30): -1.74x.
INTEREST COVERAGE RATIO
-1.91x
INTEREST COVERAGE RATIO AVG TTM
-2.36x
INTEREST COVERAGE RATIO AVG 3Y
-1.79x
INTEREST COVERAGE RATIO AVG 5Y
-3.12x
INTEREST COVERAGE RATIO AVG 10Y
-47.36x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+19.13%
CURRENT VS 3Y AVG
-6.83%
CURRENT VS 5Y AVG
+38.81%
CURRENT VS 10Y AVG
+95.97%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 323 covered companies
CURRENT VS SECTOR MEDIAN
+54.52%
vs the sector median at left
Canopy Growth Corporation
Market Cap
$373.40M
Interest Coverage Ratio
-1.91x
TTM Avg
-2.36x
3Y Avg
-1.79x
5Y Avg
-3.12x
Market Cap
$368.91M
Interest Coverage Ratio
-3.05x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
Market Cap
$366.39M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
Market Cap
$363.54M
Interest Coverage Ratio
-0.37x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.39x
Market Cap
$384.23M
Interest Coverage Ratio
-347.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$361.64M
Interest Coverage Ratio
-26.33x
TTM Avg
2025.11x
3Y Avg
2025.11x
5Y Avg
2025.11x
Market Cap
$348.85M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$348.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$345.48M
Interest Coverage Ratio
-10.12x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $373.40M | -1.91x | -2.36x | -1.79x | -3.12x |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | -3.05x | 0.61x | 0.61x | 0.61x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $366.39M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Agenus Inc. (AGEN)vs › | $363.54M | -0.37x | 0.39x | 0.39x | 0.39x |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $384.23M | -347.29x | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
| Embecta Corp. (EMBC)vs › | $348.85M | 3.07x | 2.31x | 3.74x | 3.74x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $345.48M | -10.12x | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | -375.67x | N/A | N/A | N/A |
Interest Coverage
-1.9x
Debt/Equity
0.40
Current Ratio
3.04
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.74x |
| 2026-03-31 | -2.23x |
| 2025-12-31 | -3.59x |
| 2025-09-30 | -1.92x |
| 2025-06-30 | -2.32x |
| 2025-03-31 | -0.29x |
| 2024-12-31 | -1.42x |
| 2024-09-30 | -2.16x |
| 2024-06-30 | -1.38x |
| 2024-03-31 | -5.05x |
| 2023-12-31 | -2.45x |
| 2023-09-30 | -0.26x |
| 2023-06-30 | -1.70x |
| 2023-03-31 | -19.17x |
| 2022-12-31 | -3.39x |
| 2022-09-30 | -4.90x |
| 2022-06-30 | -68.49x |
| 2022-03-31 | -25.17x |
| 2021-12-31 | -5.68x |
| 2021-09-30 | -8.08x |
| 2021-06-30 | -7.64x |
| 2021-03-31 | -49.08x |
| 2020-12-31 | -537.49x |
| 2020-09-30 | -186.65x |
| 2020-06-30 | -149.24x |
| 2019-12-31 | -85.88x |
| 2019-09-30 | -237.58x |
| 2019-06-30 | -167.75x |
| 2019-03-31 | -263.45x |
| 2018-12-31 | -153.89x |
| 2018-09-30 | -407.26x |
| 2018-06-30 | -3.75x |
| 2018-03-31 | -2.10x |
| 2017-12-31 | -137.94x |
| 2017-03-31 | 107.83x |
| 2016-12-31 | 26.26x |
| 2016-09-30 | -145.64x |
| 2016-06-30 | -86.96x |
| 2016-03-31 | -172.31x |
| 2015-12-31 | -26.50x |
| 2015-09-30 | -391.66x |
| 2015-06-30 | 51.94x |
| 2014-12-31 | -161.47x |
| 2014-09-30 | -57.56x |
| 2014-06-30 | -96.67x |
| 2014-03-31 | -312.34x |
